275 related articles for article (PubMed ID: 1673627)
1. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical localization of c-erbB-2 protein in transitional cell carcinoma of the urinary bladder.
Coombs LM; Oliver S; Sweeney E; Knowles M
J Pathol; 1993 Jan; 169(1):35-42. PubMed ID: 8094432
[TBL] [Abstract][Full Text] [Related]
3. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.
Zhau HE; Zhang X; von Eschenbach AC; Scorsone K; Babaian RJ; Ro JY; Hung MC
Mol Carcinog; 1990; 3(5):254-7. PubMed ID: 1978777
[TBL] [Abstract][Full Text] [Related]
4. An immunohistological demonstration of c-erbB-2 oncoprotein expression in primary urothelial bladder cancer.
Gardiner RA; Samaratunga ML; Walsh MD; Seymour GJ; Lavin MF
Urol Res; 1992; 20(2):117-20. PubMed ID: 1348155
[TBL] [Abstract][Full Text] [Related]
5. Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder.
Berner A; Jacobsen AB; Fosså SD; Nesland JM
Histopathology; 1993 Apr; 22(4):327-33. PubMed ID: 8099896
[TBL] [Abstract][Full Text] [Related]
6. C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value.
Mellon JK; Lunec J; Wright C; Horne CH; Kelly P; Neal DE
J Urol; 1996 Jan; 155(1):321-6. PubMed ID: 7490879
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma.
Coombs LM; Pigott DA; Eydmann ME; Proctor AJ; Knowles MA
Br J Cancer; 1993 Mar; 67(3):578-84. PubMed ID: 8439507
[TBL] [Abstract][Full Text] [Related]
8. DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder.
Wood DP; Wartinger DD; Reuter V; Cordon-Cardo C; Fair WR; Chaganti RS
J Urol; 1991 Nov; 146(5):1398-401. PubMed ID: 1942310
[TBL] [Abstract][Full Text] [Related]
9. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Coogan CL; Estrada CR; Kapur S; Bloom KJ
Urology; 2004 Apr; 63(4):786-90. PubMed ID: 15072912
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer.
Wood DP; Fair WR; Chaganti RS
J Urol; 1992 Jan; 147(1):274-7. PubMed ID: 1729545
[TBL] [Abstract][Full Text] [Related]
11. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
[TBL] [Abstract][Full Text] [Related]
12. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
Lunec J; Challen C; Wright C; Mellon K; Neal DE
Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
[No Abstract] [Full Text] [Related]
13. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
14. Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Montie JE
J Urol; 2005 Jun; 173(6):1921-2. PubMed ID: 15879779
[No Abstract] [Full Text] [Related]
15. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
[TBL] [Abstract][Full Text] [Related]
16. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 expression in breast cancer detected by immunoblotting and immunohistochemistry.
Kerns BJ; Pence JC; Huper G; Kinney RB; Iglehart JD
J Histochem Cytochem; 1990 Dec; 38(12):1823-30. PubMed ID: 1979342
[TBL] [Abstract][Full Text] [Related]
18. [int-2 and c-erbB-2 gene amplification in urological cancers].
Sato K; Kato T; Moriyama M
Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1957-63. PubMed ID: 1361954
[TBL] [Abstract][Full Text] [Related]
19. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas.
Strommer K; Hamou MF; Diggelmann H; de Tribolet N
Acta Neurochir (Wien); 1990; 107(3-4):82-7. PubMed ID: 2077857
[TBL] [Abstract][Full Text] [Related]
20. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]